Recent evidence supports an association between vitamin D deficiency and hypertension,
peripheral vascular disease, diabetes mellitus, metabolic syndrome, coronary artery
disease, and heart failure. The effect of vitamin D supplementation, however, has
not been well studied. We examined the associations between vitamin D deficiency,
vitamin D supplementation, and patient outcomes in a large cohort. Serum vitamin D
measurements for 5 years and 8 months from a large academic institution were matched
to patient demographic, physiologic, and disease variables. The vitamin D levels were
analyzed as a continuous variable and as normal (≥30 ng/ml) or deficient (<30 ng/ml).
Descriptive statistics, univariate analysis, multivariate analysis, survival analysis,
and Cox proportional hazard modeling were performed. Of 10,899 patients, the mean
age was 58 ± 15 years, 71% were women (n = 7,758), and the average body mass index
was 30 ± 8 kg/m2. The mean serum vitamin D level was 24.1 ± 13.6 ng/ml. Of the 10,899 patients, 3,294
(29.7%) were in the normal vitamin D range and 7,665 (70.3%) were deficient. Vitamin
D deficiency was associated with several cardiovascular-related diseases, including
hypertension, coronary artery disease, cardiomyopathy, and diabetes (all p <0.05).
Vitamin D deficiency was a strong independent predictor of all-cause death (odds ratios
2.64, 95% confidence interval 1.901 to 3.662, p <0.0001) after adjusting for multiple
clinical variables. Vitamin D supplementation conferred substantial survival benefit
(odds ratio for death 0.39, 95% confidence interval 0.277 to 0.534, p <0.0001). In
conclusion, vitamin D deficiency was associated with a significant risk of cardiovascular
disease and reduced survival. Vitamin D supplementation was significantly associated
with better survival, specifically in patients with documented deficiency.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.Am J Clin Nutr. 2006; 84: 18-28
- Overview of general physiologic features and functions of vitamin D.Am J Clin Nutr. 2004; 80: 1689S-1696S
- Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?.J Am Coll Cardiol. 2008; 52: 1949-1956
- 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte.J Steroid Biochem Mol Biol. 2007; 103: 533-537
- Active serum vitamin D levels are inversely correlated with coronary calcification.Circulation. 1997; 96: 1755-1760
- Vitamin D: bone and beyond, rationale and recommendations for supplementation.Am J Med. 2009; 122: 793-802
- Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.Arch Intern Med. 2007; 167: 1730-1737
- Adequacy of vitamin D supplementation in severe deficiency is dependent on body mass index.Am J Med. 2009; 122: 1056-1060
- Evidence for alteration of the vitamin D-endocrine system in obese subjects.J Clin Invest. 1985; 76: 370-373
- Decreased bioavailability of vitamin D in obesity.Am J Clin Nutr. 2000; 72: 690-693
- Body fat content and 25-hydroxyvitamin D levels in healthy women.J Clin Endocrinol Metab. 2003; 88: 157-161
- Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III.Bone. 2002; 30: 771-777
- Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population.J Clin Endocrinol Metab. 2000; 85: 4125-4130
- Vitamin D insufficiency among free-living healthy young adults.Am J Med. 2002; 112: 659-662
- A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution.Genome Res. 2010; 10: 1352-1360
- Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.J Clin Endocrinol Metab. 2001; 86: 1633-1637
- Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey.Am J Hypertens. 2007; 20: 713-719
- Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women.J Intern Med. 2007; 261: 558-565
- Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women.Hypertension. 2008; 52: 828-832
- Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004).Am J Cardiol. 2008; 102: 1540-1544
- 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.Arch Intern Med. 2008; 168: 1174-1180
- Plasma vitamin D and mortality in older men: a community-based prospective cohort study.Am J Clin Nutr. 2010; 4: 841-848
- Vitamin D levels and mortality in type 2 diabetes.Diabetes Care. 2010; 10: 2238-2243
- Vitamin D and mortality in older men and women.Clin Endocrinol Oxf. 2009; 71: 666-672
- Vitamin D status and arterial hypertension: a systematic review.Nat Rev Cardiol. 2009; 6: 621-630
- Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab. 2011; 96: 1911-1930
Article Info
Publication History
Published online: November 10, 2011
Accepted:
September 13,
2011
Received in revised form:
September 13,
2011
Received:
July 18,
2011
Identification
Copyright
© 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
